New Content
 | Publication from Nature Clinical Practice, "Will focal therapy become a standard of care for men with localized prostate cancer?" by H. Ahmed, D. Pendse, R. Illing, C. Allen, J. van der Meulen, and M. Emberton is located on the Publications section. |
| Sonablate® Brochure |
Events
| Focus Surgery staff recently participated in the IEEE International Ultrasonics Symposium, held in New York, NY, from October 28-31, 2007. This conference primarily focuses on the sharing and discussion of research and development activities in the areas of ultrasonics in general, and to specific interest to Focus Surgery, to therapeutic ultrasound in particular. Therapeutic ultrasound talks and posters from academia and industry focused this year mainly on on the following topics: therapeutic ultrasound applications in brain, molecular imaging, and therapeutic ultrasound interactions with drugs and gene therapy, all active topics of research. Overall, approximately 1200 scientists participated and around 800 papers were presented. |
| Focus Surgery staff recently participated in the CURC (Canadian Urology Research Consortium) and the CUOG (Canadian Urologic Oncology Group), held in Vancouver, British Columbia, Canada, from October 12-14, 2007. The purpose of this meeting was to have research and new drug topics discussed among the pharmaceutical companies and some well-established research oriented centers for urological applications. These applications were BPH; cancer of the prostate, bladder, etc. The special session on HIFU was organized by Dr. Laurence Klotz, University of Toronto. Narendra Sanghvi, Focus Surgery, Inc., gave a presentation on "The Sonablate® HIFU: Past, Present and Future of Prostate Cancer Treatment," that included basic physics of HIFU. He also explained how the Sonablate® 500 components - probe, transducer, SonachillTM, probe arm and software - have embedded these basic principles in their design. Also briefly covered was the Sonablate® 500 worldwide locations, with an emphasis on where the main centers are located in Canada. The other presentations included "Ablatherm by HIFU Technology: Different Engineering Strategies Resulting in Unique Clinical Device," by Dr. John Rewcastle. This presentation was identical to the article published in Contemporary Urology, Vol. 19, No. 10, October, 2007. However, it was with corrected slides on cavitation and concluded that both devices were undergoing similar FDA approved protocol and needed long term safety and efficacy data in North America. Following this was clinical presentations given by urology doctors who emphasized the need for more clinical data and systematic documentations. It was recognized that HIFU is a promising technology, but lacks long term clinical data and must be used with caution. |
Upcoming Events
|
The 2008 American Urological Association Annual Meeting will take place in Orlando, Florida on May 17-22, 2008. Please visit Focus Surgery at Booth #2729. |
Press Releases/News Stories
|
August 14, 2007 - Misonix Highlights Recent Duke University Study Revealing Significant New Cancer Treatment May Be Possible with HIFU Technology |
|
August 8, 2007 - High Intensity Focused Ultrasound (HIFU) now Available at Center in Argentina |
|
July 30, 2007 - New Software for High Intensity Focused Ultrasound (HIFU) Treatment Against Prostate Cancer |
|
June 22, 2007 - HIFU for Prostate Cancer in Niagra Falls |
|
June 6, 2007 - Major Milestones Announced for Sonablate 500 HIFU Treatment of Prostate Cancer at Annual American Urology Association Conference |
|
March 29, 2007 - Misonix Announces First SB500 HIFU Prostate Cancer Hemiablation Treatment Delivering Perfect Scores for Patient Continence and Potency |
|
March 26, 2007 - Misonix Announces First Global HIFU Prostate Cancer Treatment Clinical Registry |
|
March 22, 2007 - Misonix Announces First Successful HIFU Procedures for Human Kidney Cancer |
|
March 20, 2007 - Misonix Spotlights HIFU Medical Devices for Prostate and Kidney Cancer Treatment at European Association of Urology Conference 2007 |
|
March 6, 2007 - Misonix Enlists Partnermed to Distribute Market Leading Sonablate® 500 HIFU Prostate Cancer Treatment Device in Northern Europe |
|
February 16, 2007 - Misonix Enlists Experienced Sonablate® 500 Distributor Takai Hospital Supply to Market Leading HIFU Prostate Cancer Treatment Device in Turkey, Greece and Cyprus - First Sale Reported in Turkey |
The Sonablate® is an investigational device limited by Federal Law to investigational use in the United States.
Send mail to
focus@focus-surgery.com with questions or comments about this
web site.
Copyright © 2004-2007
Designed By Fishers Graphics